Company · CIK 1757097
Centogene N.V.
| CIK | 1757097 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Incorporated in | P7 |
| Business address | Germany |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-04-23 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-239735 | 2020-07-07 | 2020-07-10 | 3 | |
| 333-234177 | 2019-10-11 | 2019-11-08 | 4 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2020-07-10 | 424B4Final prospectus | 333-239735 | 0001047469-20-004069 |
| 2020-07-09 | EFFECTDeclared effective | 333-239735 | 9999999995-20-001751 |
| 2020-07-07 | F-1Registration filed | 333-239735 | 0001047469-20-004012 |
| 2020-06-26 | DRSDraft made public | 377-03246 | 0000912057-20-000191 |
| 2019-11-08 | 424B4Final prospectus | 333-234177 | 0001047469-19-006180 |
| 2019-11-06 | EFFECTDeclared effective | 333-234177 | 9999999995-19-002504 |
| 2019-10-28 | F-1/AAmendment | 333-234177 | 0001047469-19-005919 |
| 2019-10-11 | F-1Registration filed | 333-234177 | 0001047469-19-005715 |
| 2018-10-31 | DRSDraft made public | 377-02343 | 0000912057-18-000453 |